Clinical Trials in the Wake of COVID-19
ACT’s Lisa Henderson interviews John Potthoff, PhD, CEO of Elligo Health Research, about decentralizing and restarting clinical trials amid the COVID-19 pandemic.
Navigating the Changing Landscape of Clinical Research
Elevating Clinical Research with Technology Solutions
eCOA IRT Thought Leadership Series
